Part 1: Hepatitis C (23 mins)

Expert commentary from CCO on how providers can act as advocates for increased access to HCV care for persons who use drugs and incarcerated individuals

Oluwaseun Falade-Nwulia, MBBS, MPH Released: December 18, 2019

Watch this video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.

Paul Y. Kwo, MD
Program Director Manal F. Abdelmalek, MD, MPH Oluwaseun Falade-Nwulia, MBBS, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ US Physicians: maximum of 1.5 Medical Knowledge MOC point(s) Released: December 17, 2019 Expired: No longer available for credit

Part 1: Hepatitis C (23 mins)

Part 2: Hepatitis B (25 mins)

Part 3: NAFLD/NASH (30 mins)

Part 4: Question and Answer (11 mins)

HCV elimination approaches: Slides from the Clinical Care Options Symposium at the liver meeting 2019, with Oluwaseun Falade-Nwulia, MBBS, MPH

Oluwaseun Falade-Nwulia, MBBS, MPH Released: November 11, 2019

Expert commentary on the importance of improving HCV treatment uptake in persons who inject drugs and effective linkage-to-care strategies

Oluwaseun Falade-Nwulia, MBBS, MPH Released: October 14, 2019